In breast cancer, this mostly involves defective repair of DNA double-stranded breaks by homologous recombination (HR), e.g. as is known to occur in tumor cells arising in carriers of either BRCA1 or BRCA2 germline mutations [33]. Here, BRCA2 is linked to breast cancer.